James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 6,244 shares at $57.08 ($362K) on 2019-05-08, disclosed to the SEC on 2019-05-10.
Scheduled sale ($362k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.08 | 600 | $34K | 9.5% |
| 2 | $57.15 | 358 | $20K | 5.7% |
| 3 | $57.15 | 700 | $40K | 11.1% |
| 4 | $57.73 | 542 | $31K | 8.6% |
| 5 | $57.82 | 1,044 | $60K | 16.7% |
| 6 | $57.89 | 1,258 |
| $73K |
| 20.1% |
| 7 | $58.86 | 600 | $35K | 9.8% |
| 8 | $58.91 | 1,142 | $67K | 18.6% |
| Total | $57.94 avg | 6,244 | $362K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |